Results 21 to 30 of about 86,041 (135)
Circulation, 1998 To the Editor: In a recent issue of Circulation , Brown and Vaughan1 reviewed ACE inhibitors. They stated that captopril and lisinopril are active drugs and listed 7 other ACE inhibitors approved in the United States that are inactive prodrugs until metabolized in the liver.
openaire +2 more sources
PLoS ONE, 2021 IntroductionThis meta-analysis aimed to summarize the available evidence to compare angiotensin-converting enzyme (ACE) inhibitors with angiotensin II receptor blockers (ARBs) on improving insulin sensitivity in hypertensive patients.MethodsRandomized ...
Jia Yao +5 more
doaj +1 more source
ACE INHIBITOR POSSIBILITIES IN CLINICAL PRACTICE: WHAT WE KNOW ABOUT THEM?
Рациональная фармакотерапия в кардиологии, 2016 New possibilities of ACE inhibitors application on the base of international trails review are presented. Traditional therapy areas of ACE inhibitors (hypertension, heart failure) are well known.
D. V. Nebieridze, A. S. Safarian
doaj +1 more source
Kidney & Blood Pressure Research, 2018 Background/Aims: Whether angiotensin-converting enzyme (ACE) inhibitors or angiotensin II receptor blockers (ARB) could benefit patients with diabetes and albuminuria remains controversial.
Kanran Wang +7 more
doaj +1 more source
International Journal of Pharmacy & Integrated Health SciencesBackground: There is good evidence that angiotensin-converting enzyme (ACE) inhibitors are beneficial after myocardial infarction (MI). However, it is not known how widely this evidence is used in practice or whether all eligible patients receive this ...
Fiaz Alam +6 more
doaj +1 more source
FEBS Open Bio, 2015 Angiotensin converting enzyme (ACE) is a zinc‐dependent dipeptidyl carboxypeptidase with an essential role in blood pressure homeostasis in mammals.
Charlotte Harrison, K. Ravi Acharya
doaj +1 more source
Conformational fingerprint of blood and tissue ACEs: Personalized approach.
PLoS ONE, 2018 BackgroundThe pattern of binding of monoclonal antibodies (mAbs) to 18 epitopes on human angiotensin I-converting enzyme (ACE)-"conformational fingerprint of ACE"-is a sensitive marker of subtle conformational changes of ACE due to mutations, different ...
Sergei M Danilov +8 more
doaj +1 more source
ACE inhibitors potently reduce vascular inflammation, results of an open proof-of-concept study in the abdominal aortic aneurysm. [PDF]
PLoS ONE, 2014 Independent of their blood pressure lowering effect, ACE inhibitors are thought to reduce vascular inflammation. The clinical relevance of this effect is unclear with the current knowledge.
Kim E Kortekaas +6 more
doaj +1 more source
Estimation of angiotensin-converting enzyme inhibitors protein binding degree using chromatographic hydrophobicity data [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2015 Introduction. Angiotensin-converting enzyme (ACE) inhibitors represent a significant group of drugs primarily used in the treatment of hypertension and congestive heart failure. Objective.
Trbojević-Stanković Jasna +2 more
doaj +1 more source
Российский кардиологический журнал, 2005 Vasoregulatory endothelial function and dynamics of chronic inflammatory markers were investigated in patients with chronic heart failure (CHF), receiving standard therapy including ACE inhibitors, or ACE inhibitors plus aspirin.
A. P. Rebrov, E. Yu. Sazhina, M. I. Toma
doaj